MRI differential diagnosis of inflammatory bowel disease
Date |
---|
2018-10-04 |
ISBN 978-609-95750-6-3 (Online)
The content of the abstracts presented is the responsibility of their authors and co-authors. The abstracts are arranged in sequence according to the congress program.
Learning objective: Describe Etiology, pathogenesis, clinical manifestation, classification of IBD. Imagining modality, Activity grading, Differential diagnosis and Structural report. Abstract details: Inflammatory bowel diseases (IBD), consisting of ulcerative colitis (UC) and Crohn's disease (CD), have become more common in different regions of the world over the past decades. Its incidence and prevalence in developing countries is steadily rising and has been attributed to the rapid modernization and Westernization of the population. Magnetic resonance enterocolonography (MREC) has become the modality of choice in the diagnosis and followup of inflammatory bowel disease (IBD), and could potentially play a similar role in a variety of other small bowel disorders. Cross-sectional imaging offers the opportunity to detect and stage inflammatory, obstructive and fistulizing CD (ECCO 2H; ECCO–ESGAR 3C). Is fundamental at: First diagnosis to stage disease (ECCO–ESGAR 2A; ACG guidlines). Understand the location, severity and length of CD inflammation (ACG guidlines) To monitor followup, for therapeutic monitoring in colonic CD (ECCO–ESGAR 4E) MRI alone is not a tool for IBD diferential diagnosis. Clinical features are helpful for differential diagnosis: patient history, physical examination, laboratory testing, stool test, colonoscopy with histology.